Neurocrine Biosciences, Inc. (NBIX) has announced that the U.S. Food and Drug Administration has granted approval for CRENESSITY (crinecerfo...
Showing posts with label Neurocrine's CRENESSITY Gains FDA Approval For Treating Congenital Adrenal Hyperplasia. Show all posts
Showing posts with label Neurocrine's CRENESSITY Gains FDA Approval For Treating Congenital Adrenal Hyperplasia. Show all posts
Friday, December 13, 2024
Posts
Posts